Spartan Nurse Perspectives: Respiratory Syncytial Virus vaccine for older adults

By: Kristin Castine, DNP, ANP-BC

Assistant Professor

The changing color of leaves signals the start of fall and marks the beginning of cold, influenza, and respiratory syncytial virus (RSV) season. RSV is a common virus that affects the nose, throat, and respiratory system. It spreads through droplets from coughing or sneezing or direct contact with an infected person or surface. Symptoms can resemble the common cold, including runny nose, congestion, decreased appetite, cough, sneezing, fever, and wheezing. RSV typically causes mild symptoms in healthy individuals, but infants and older adults face a higher risk of severe illness, hospitalization, and death. Diagnosis is confirmed through testing at urgent care, outpatient clinics, or emergency rooms.

There is currently no approved medication to cure RSV, but treatment can help with symptom relief using over-the-counter analgesics such as Motrin or Tylenol, increased fluids, and rest. Sometimes, your provider may also prescribe bronchodilators and corticosteroids for acute wheezing.

To reduce the risk of RSV, practice good hand hygiene, avoid contact with infected individuals, and consider vaccination if eligible. The Centers for Disease Control and Prevention recommends the RSV vaccine for those ages 75 and older and for individuals ages 60-74 with conditions such as COPD, heart failure, diabetes, obesity, or for those residing in extended care facilities. The best time to get the RSV vaccine is in late summer or early fall. Common side effects include mild injection site reactions, headache, and muscle or joint pain. These usually resolve within one to two days and can be managed with over-the-counter analgesics.

Now is a good time to consider the RSV vaccine for yourself and your loved ones. If you have additional questions, consult with your primary care provider or visit the CDC’s website on RSV at cdc.gov/rsv/older-adults/index.html.

Published Sept. 26